Lipophilic drug compositions

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S484000, C424S489000, C514S359000, C514S365000, C514S385000

Reexamination Certificate

active

07125568

ABSTRACT:
The invention is directed to biologically active lipophilic compositions comprising a biologically active covalently attached to, or encapsulated within, a lipid. Preferably, a biologically active agent is both covalently attached to a lipid and encapsulated within a lipid composition. Preferred lipid components include triglycerides and fatty acids. The resulting composition is preferably adapted for oral administration.

REFERENCES:
patent: 3931213 (1976-01-01), Kaminski et al.
patent: 3950351 (1976-04-01), Rossignol et al.
patent: 4186129 (1980-01-01), Huth et al.
patent: 4315018 (1982-02-01), Rossignol
patent: 4877561 (1989-10-01), Iga et al.
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 5043165 (1991-08-01), Radhakrishnan
patent: 5340587 (1994-08-01), Mihalko et al.
patent: 5512671 (1996-04-01), Piantadosi et al.
patent: 5534499 (1996-07-01), Ansell
patent: 5565571 (1996-10-01), Barbachyn et al.
patent: 5576016 (1996-11-01), Amselem et al.
patent: 5599831 (1997-02-01), Poretz et al.
patent: 5643907 (1997-07-01), Swirska et al.
patent: 5662932 (1997-09-01), Amselem et al.
patent: 5668286 (1997-09-01), Yamada et al.
patent: 5688525 (1997-11-01), Adler-Moore et al.
patent: 5688792 (1997-11-01), Barbachyn et al.
patent: 5700777 (1997-12-01), Sarin et al.
patent: 5700799 (1997-12-01), Hutchinson et al.
patent: 5716637 (1998-02-01), Anselem et al.
patent: 5719154 (1998-02-01), Tucker et al.
patent: 5795589 (1998-08-01), Mayer et al.
patent: 5798348 (1998-08-01), Alemany
patent: 5817334 (1998-10-01), Schmidt et al.
patent: 5856348 (1999-01-01), Rossignol
patent: 5859038 (1999-01-01), Rossignol
patent: 5874111 (1999-02-01), Maitra et al.
patent: 5886013 (1999-03-01), Rossignol
patent: 5935591 (1999-08-01), Rossignol et al.
patent: 5936092 (1999-08-01), Shen et al.
patent: 5939096 (1999-08-01), Clerc et al.
patent: 5962437 (1999-10-01), Kucera et al.
patent: 5965590 (1999-10-01), Rossignol
patent: 5968961 (1999-10-01), Rossignol
patent: 5989583 (1999-11-01), Amselem
patent: 6011020 (2000-01-01), Gold et al.
patent: 6020353 (2000-02-01), Rossignol
patent: 6060080 (2000-05-01), Kikuchi et al.
patent: 6071532 (2000-06-01), Chaikof et al.
patent: 6080725 (2000-06-01), Marciani
patent: 6117894 (2000-09-01), Rossignol
patent: 6120751 (2000-09-01), Unger
patent: 6147204 (2000-11-01), Gold et al.
patent: 6153119 (2000-11-01), Sung
patent: 6166056 (2000-12-01), Thomas et al.
patent: 6168778 (2001-01-01), Janjic et al.
patent: 6180136 (2001-01-01), Larson et al.
patent: 6225445 (2001-05-01), Shen et al.
patent: 6241999 (2001-06-01), Ye et al.
patent: 6287591 (2001-09-01), Semple et al.
patent: 6288238 (2001-09-01), Hollingsworth et al.
patent: 6337329 (2002-01-01), Cochran et al.
patent: 2001/0056116 (2001-12-01), Shashoua
patent: 2002/0177609 (2002-11-01), Swindell et al.
patent: 2003/0023104 (2003-01-01), Whittaker et al.
patent: 0 316 594 (1989-05-01), None
patent: WO 96/22303 (1996-07-01), None
patent: WO 00/59482 (2000-10-01), None
patent: WO 01/45744 (2001-06-01), None
VATISTAS, “Initial experiences With the Use of Nitazoxanide in the Treatment of Equine Protozoal Encephalitis in Northern California”,Equine Practice, May 1999, 18-21, vol. 21, No. 5.
Gillard, J. et al., “The Release of Quinidine Sulphate from Inert, Hydrophilic and Lipophilic Matrices,”Sciences Techniques et Practiques Pharmaceutiques, 1987, pp. 492-500, vol. 3(6).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Lipophilic drug compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipophilic drug compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipophilic drug compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3706139

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.